- Panalgo, headquartered in Boston, Massachusetts, specializes in healthcare analytics, focusing on real-world data solutions to enhance patient insights and treatment strategies for life sciences organizations.
- In May 2025, Panalgo launched two innovative products, LinQNotes and Ella AI, aimed at improving the accessibility and analysis of both structured and unstructured healthcare data.
- Panalgo has established partnerships with biotech companies, exemplified by a case study where they helped create a regulatory-grade real-world control dataset for ultra-rare diseases using their NorstellaLinQ platform.
- The ideal buyers for Panalgo's solutions are healthcare analytics teams within pharmaceutical and biotech companies, as they address critical pain points related to understanding treatment decisions and patient outcomes through advanced data insights.
Panalgo's workforce is organized into eight departments, with the largest being Operations, which comprises 25 employees, followed closely by Information Technology with 21 employees. The Executive team consists of 6 members, while Engineering and Sales each have 4 employees. This distribution indicates a strong emphasis on operational and technological functions, reflecting the company's focus on software development. The presence of smaller departments such as Finance and Administrative suggests a streamlined approach to support functions.
The company's headquarters is located in Boston, Massachusetts, which is home to 33 employees, representing a significant concentration of the workforce. Other locations include New Orleans, San Francisco, Melrose Park, New York, Bluffton, Brighton, Overland Park, and Wakefield, each contributing a single employee. The 'Other' category accounts for 38 employees, indicating a distributed workforce model that likely supports remote work arrangements. This geographic diversity enhances the company's operational flexibility while maintaining a central hub in Boston.
